Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Intervention Indication Therapeutic Area Year Actions
Romiplostim for idiopathic thrombocytopenic purpura in adult patients who are refractory to other treatments Romiplostim (Nplate; AMG-531) Idiopathic thrombocytopenic purpura Haematology 2019 View  |  Download
Romosozumab for osteoporosis in men Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Romosozumab for postmenopausal osteoporosis Romosozumab (Evenity; AMG-785) Osteoporosis Musculoskeletal System 2017 View  |  Download
Ronopterin for Moderate to Severe Traumatic Brain Injury Ronopterin (VAS-203) Traumatic brain injury (TBI) Neurology 2018 View  |  Download
Ropeginterferon alfa-2b for polycythaemia vera without symptomatic splenomegaly Ropeginterferon alfa 2-b (P-1101; AOP2014; Pegylated-Proline-interferon alpha-2b) Polycythaemia vera Haematological Cancer and Lymphomas 2019 View  |  Download
Rovalpituzumab tesirine for the treatment of relapsed or refractory small cell lung cancer Rovalpituzumab tesirine (SC16LD6.5; Rova-T) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2017 View  |  Download
Roxadustat for Renal Anaemia in Chronic Kidney Disease Roxadustat (FG-4592) Renal anaemia Haematology , Nephrology 2018 View  |  Download
Rozanolixizumab for generalised myasthenia gravis Rozanolixizumab (UCB7665) Myasthenia gravis (MG) Musculoskeletal System 2022 View  |  Download
Rucaparib (Rubraca) for platinum-sensitive, high-grade serous or endometrioid epithelial ovarian cancer, primary peritoneal or fallopian tube cancer Rucaparib (Rubraca; PF-1367338) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2018 View  |  Download
Rucaparib for metastatic castration-resistant prostate cancer associated with homologous recombination deficiency Rucaparib (Rubraca; PF-1367338) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
1 2 88 89 90 91 92 115 116
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications